PHOENIX, Arizona — Patients treated with radiofrequency intradiscal biacuplasty (IDB) for discogenic low back pain show maintenance of improvements in pain and physical function for as long as a year ...
Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that ...
(HealthDay News) — High-quality studies evaluating nonoperative treatments for reducing discogenic low back pain are lacking, according to a review published in the July 15 issue of Spine. Young Lu, ...
In a recent study published in Biomaterials, researchers developed a novel non-viral gene therapy for discogenic back pain (DBP) by delivering a developmental-type transcription factor, Forkhead Box ...
(Nanowerk News) Disc-related back pain may one day meet its therapeutic match: gene therapy delivered by naturally derived nanocarriers that, a new study shows, repairs damaged discs in the spine and ...
On Sunday, Mesoblast Limited (NASDAQ: MESO) provided feedback received from the U.S. Food & Drug Administration (FDA) on potential filing of a Biologics License Application (BLA) for its allogeneic ...
BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation in ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results